Infectious Disease
Pneumonia
More in Pneumonia
DEVICE trial finds higher success rates versus direct laryngoscope in the critically ill
Xacduro lands approval for hospital-acquired cases caused by one of CDC's "urgent threats"
Benefit observed even in adults with levels of aerobic activity below guideline recommendations
Advisors unanimously recommend agency approve drug combination for healthcare-associated cases
One big benefit amid similar overall results for high-dose prophylaxis in critically ill patients
Death by day 28 occurred in 6% of those who received the drug in the ICU vs 12% of placebo group
Other notable changes include new guidance on polio, MMR, hepatitis B, and pneumococcal vaccines
A 67-year-old man presented to the ED appearing ill with complaints of productive cough, dyspnea, pleuritic chest pain, and fever for the past 5 days. Can you diagnose the patient?